SCHEMBL8963465

SCHEMBL8963465

Cc1[nH]c(-c2ccc(C(C)(C)C)cc2)nc1CN1CCN(C(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.80

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.57
NR1I2 O75469 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
CNR1 P21554 1/20 0.57
HRH1 P35367 1/20 0.57
OPRK1 P41145 1/20 0.57
PDE4D Q08499 1/20 0.57
KCNH2 Q12809 1/20 0.57
GHSR Q92847 1/20 0.57
DRD2 P14416 1/20 0.53
DRD4 P21917 1/20 0.53
DRD3 P35462 1/20 0.53
OPRD1 P41143 1/20 0.53
GNRHR P30968 4/20 0.51
CTSS P25774 7/20 0.49
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8963810 0.92 LMNA (0.49) LMNANR1I2ADORA3CNR1HRH1
SCHEMBL8963668 0.90 DRD2 (0.64) LMNANR1I2ADORA3CNR1HRH1
Lifarizine SCHEMBL676318 0.89 DRD2 (0.57) LMNAADORA3CNR1HRH1OPRK1
SCHEMBL8964163 0.89 DRD2 (0.51) LMNANR1I2ADORA3CNR1HRH1
Lifarizine SCHEMBL8963776 0.88 DRD2 (0.56) LMNAADORA3CNR1HRH1OPRK1
SCHEMBL8963644 0.88 DRD3 (0.56) LMNANR1I2ADORA3CNR1HRH1
SCHEMBL8963673 0.86 GNRHR (0.46) LMNANR1I2ADORA3CNR1HRH1
SCHEMBL8964060 0.85 DRD2 (0.53) LMNAOPRK1DRD2DRD4DRD3
SCHEMBL9424741 0.84 DRD3 (0.55) LMNANR1I2ADORA3CNR1HRH1
SCHEMBL8963974 0.84 DRD3 (0.59) LMNANR1I2ADORA3CNR1HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5514800-A CALCIUM CHANNEL BLOCKERS, CEREBRAL ISCHEMIA SYNTEX PHARMACEUTICALS, LTD. (GB) 1996-05-07 US disclosed
US-5276034-A Cardiovascular disorders, nervous system disorders, diuretics, antiischemic agents or antispasmodic agents SYNTEX PHARMACEUTICAL LTD. (GB) 1994-01-04 US disclosed
US-5252736-A Calcium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1993-10-12 US disclosed
EP-0289227-B1 SUBSTITUTED IMIDAZOLYL-ALKYL-PIPERAZINE AND -DIAZEPINE DERIVATIVES SYNTEX PHARMACEUTICALS LTD. (GB) 1992-04-08 EP disclosed
US-5091428-A Calcium channel blockers preferential for cerebral blood vessels SYNTEX PHARMACEUTICALS, LTD. (BM) 1992-02-25 US disclosed
US-5043447-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1991-08-27 US disclosed
US-5010075-A Antiepilepic, hypotensive, antiarrhythmia, antiischemic agent SYNTEX PHARMACEUTICALS LTD. (GB) 1991-04-23 US disclosed
US-4935417-A CALCIUM CHANNEL BLOCKERS SYNTEX PHARMACEUTICALS LTD. (BM) 1990-06-19 US disclosed
US-4829065-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1989-05-09 US disclosed
EP-0289227-A1 Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS LTD. (GB) 1988-11-02 EP disclosed